CHI

AM Best Downgrades and Withdraws Credit Ratings of Conifer Holdings, Inc. and Subsidiaries

Retrieved on: 
Thursday, March 14, 2024
Finance, Data Analytics, Professional Services, Other Professional Services, Insurance, ERM, ALL, News, CHI, Credit, AM Best, CIC, Good, Conifer, Risk management

Concurrently, AM Best has placed all of these Credit Ratings (ratings) under review with negative implications.

Key Points: 
  • Concurrently, AM Best has placed all of these Credit Ratings (ratings) under review with negative implications.
  • At the same time, AM Best has withdrawn all of these ratings as the company has requested to no longer participate in AM Best’s interactive rating process.
  • For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best's Credit Ratings .
  • For information on the proper use of Best’s Credit Ratings, Best’s Performance Assessments, Best’s Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Best’s Ratings & Assessments .

Alphawave Semi Demonstrates 3nm Silicon-Proven 24Gbps Universal Chiplet ExpressTM (UCIeTM) Subsystem for High-Performance AI Infrastructure

Retrieved on: 
Tuesday, March 12, 2024
Networks, Internet, Hardware, Artificial Intelligence, Data Management, Technology, IOT (Internet of Things), Semiconductor, HBM, Info, Innovation, Integration, CHI, CXL, CXS, PCI Express, Multi, Marketing, OIP, Semi, Ecosystem, PHY, Multimedia, Computation, UCIe, TSMC, Silicon, Video game

This new silicon-proven Universal Chiplet Interconnect Express (UCIeTM) subsystem expands Alphawave Semi’s portfolio and leadership in connectivity silicon.

Key Points: 
  • This new silicon-proven Universal Chiplet Interconnect Express (UCIeTM) subsystem expands Alphawave Semi’s portfolio and leadership in connectivity silicon.
  • It paves the way for a robust, open chiplet ecosystem that accelerates connectivity and compute for high-performance AI systems.
  • An industry-first live demo of Alphawave Semi’s 24Gbps UCIe silicon platform on the TSMC 3nm process was recently unveiled at the Chiplet Summit in Santa Clara, CA.
  • View the full release here: https://www.businesswire.com/news/home/20240311461384/en/
    Alphawave Semi 24Gbps UCIe 3nm silicon platform (Graphic: Business Wire)
    Alphawave Semi’s 3nm UCIe complete PHY + Controller subsystem is capable of 24Gbps data rates, delivering high bandwidth density at extremely low power and low latency.

Leading Healthcare Strategist Jeff Moser Joins Compass One Healthcare

Retrieved on: 
Thursday, February 8, 2024
Managed Care, Hospitals, Health, Practice Management, Strategic planning, Economics, Psychology, Compass One, Texas Christian University, Senior, Hospital, Compass, Springfield College, Cardinal Health, CHI, Nursing

Jeff Moser, a leading healthcare strategist with over 30 years of experience, has joined Compass One Healthcare (Compass One) as the Senior Vice President of Partner Strategy.

Key Points: 
  • Jeff Moser, a leading healthcare strategist with over 30 years of experience, has joined Compass One Healthcare (Compass One) as the Senior Vice President of Partner Strategy.
  • In his new role, Moser leads Compass One’s partner engagement strategy, focusing on identifying new opportunities, creating value, and growing existing relationships with hospitals and health systems.
  • “Jeff knows the key drivers of health system financial, operational, and clinical performance, and he is known for being a trusted advisor to healthcare C-Suite executives and critical decision-makers,” said Compass One chief executive officer Bobby Kutteh.
  • During his time at Sg2, Moser was a trusted advisor to Compass One on critical drivers of health system financial, operational, and clinical performance.

Tenstorrent Selects Blue Cheetah Chiplet Interconnect IP For Its AI and RISC-V Solutions

Retrieved on: 
Tuesday, February 6, 2024
CHI, National Oceanography Centre, Southampton, AXI, ACE, Bow, OCP, PHY, UCIe

SUNNYVALE, Calif., Feb. 6, 2024 /PRNewswire/ -- Tenstorrent and Blue Cheetah Analog Design today announced that Tenstorrent has licensed Blue Cheetah's die-to-die interconnect IP for its AI and RISC-V chiplet solutions.

Key Points: 
  • SUNNYVALE, Calif., Feb. 6, 2024 /PRNewswire/ -- Tenstorrent and Blue Cheetah Analog Design today announced that Tenstorrent has licensed Blue Cheetah's die-to-die interconnect IP for its AI and RISC-V chiplet solutions.
  • By selecting Blue Cheetah, Tenstorrent aims to accelerate its own as well as its customers' and partners' development of chiplet-based AI and RISC-V solutions.
  • Blue Cheetah currently provides its chiplet interconnect IP solutions in 4 nm, 5nm, 7nm, 12nm, and 16nm process technologies.
  • "Tenstorrent delivers highly customized, high-performance AI and RISC-V chiplet solutions tailored to specific workloads and applications," said Elad Alon, CEO of Blue Cheetah.

Lumosa Therapeutics and CHI Memorial announce new study for acute stroke

Retrieved on: 
Friday, February 2, 2024
CHI, CCNR, Stroke, BRIGHT, Patient, Tissue plasminogen activator, Brain, Therapy, Hope, Doctor of Philosophy, U.S. FDA, Pharmaceutical industry

TAIPEI and CHATTANOOGA, Tenn., Feb. 2, 2024 /PRNewswire/ -- Lumosa Therapeutics (Lumosa; 6535.TWO), together with CHI Memorial have announced the initiation of a Phase 2b clinical trial for LT3001, a groundbreaking drug for treating acute stroke.

Key Points: 
  • TAIPEI and CHATTANOOGA, Tenn., Feb. 2, 2024 /PRNewswire/ -- Lumosa Therapeutics (Lumosa; 6535.TWO), together with CHI Memorial have announced the initiation of a Phase 2b clinical trial for LT3001, a groundbreaking drug for treating acute stroke.
  • Lumosa and CHI Memorial aim to redefine what is possible in preventing stroke disability and impairment.
  • In December 2023, CHI Memorial achieved a significant milestone by enrolling the first U.S. patient in the Lumosa 203, double-blinded stroke study.
  • Lumosa and CHI Memorial are committed to advancing medical innovation and improving the lives of stroke patients worldwide.

Lumosa Therapeutics and CHI Memorial announce new study for acute stroke

Retrieved on: 
Friday, February 2, 2024
CHI, CCNR, Stroke, BRIGHT, Patient, Tissue plasminogen activator, Brain, Therapy, Hope, Doctor of Philosophy, U.S. FDA, Pharmaceutical industry

TAIPEI and CHATTANOOGA, Tenn., Feb. 2, 2024 /PRNewswire/ -- Lumosa Therapeutics (Lumosa; 6535.TWO), together with CHI Memorial have announced the initiation of a Phase 2b clinical trial for LT3001, a groundbreaking drug for treating acute stroke.

Key Points: 
  • TAIPEI and CHATTANOOGA, Tenn., Feb. 2, 2024 /PRNewswire/ -- Lumosa Therapeutics (Lumosa; 6535.TWO), together with CHI Memorial have announced the initiation of a Phase 2b clinical trial for LT3001, a groundbreaking drug for treating acute stroke.
  • Lumosa and CHI Memorial aim to redefine what is possible in preventing stroke disability and impairment.
  • In December 2023, CHI Memorial achieved a significant milestone by enrolling the first U.S. patient in the Lumosa 203, double-blinded stroke study.
  • Lumosa and CHI Memorial are committed to advancing medical innovation and improving the lives of stroke patients worldwide.

500th Use of the Galaxy System™ in the United States Conducted at CHI Memorial in Tennessee

Retrieved on: 
Wednesday, January 24, 2024
Patient, Health, SAN, Macquarie University Hospital, University, CHI, Quality of life, Fluoroscopy, Galaxy, Robotics, Doctor of Philosophy, 500th, Biopsy, Lung, Physician

SAN CARLOS, Calif., Jan. 24, 2024 (GLOBE NEWSWIRE) -- Medical robotics innovator Noah Medical today announced that the 500th use of its Galaxy System in the United States was conducted at CHI Memorial in Chattanooga by Dr. Krish Bhadra.

Key Points: 
  • SAN CARLOS, Calif., Jan. 24, 2024 (GLOBE NEWSWIRE) -- Medical robotics innovator Noah Medical today announced that the 500th use of its Galaxy System in the United States was conducted at CHI Memorial in Chattanooga by Dr. Krish Bhadra.
  • CHI Memorial is also the first hospital in Tennessee to adopt the Galaxy technology.
  • The procedure marks an important step for Noah in the commercial rollout of its image-integrated robotic assisted bronchoscopy system in the U.S.
  • To learn more about Noah Medical and the Galaxy System, please visit noahmed.com .

The Cooper Housing Institute Funds National Study on Housing Choice Vouchers

Retrieved on: 
Wednesday, November 15, 2023
Ward, Research, HCV, Policy, Housing, Section 8, PHA, University of California, Berkeley, Section, Homelessness, RAND, Veteran, Bijoux Terner, RAND Corporation, Partnership, Doctor of Philosophy, CHI, UC, Management

IRVINE, Calif., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Today, the Cooper Housing Institute (CHI), a private research foundation dedicated to solving the affordable housing crisis in the U.S., awarded a grant to the nonprofit, nonpartisan RAND Corporation (RAND) to fund research into the Housing Choice Voucher (HCV) program.

Key Points: 
  • IRVINE, Calif., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Today, the Cooper Housing Institute (CHI), a private research foundation dedicated to solving the affordable housing crisis in the U.S., awarded a grant to the nonprofit, nonpartisan RAND Corporation (RAND) to fund research into the Housing Choice Voucher (HCV) program.
  • The study will aim to identify actionable steps public housing authorities (PHAs) can take that could lead to improvements in the efficacy and efficiency of this vital affordable housing program.
  • The study aims to identify policy and operational choices within PHA control that could loosen these hurdles and increase voucher utilization.
  • “The housing choice voucher program is a private-public partnership that helps our nation’s low-income families, seniors and veterans afford a safe, decent place to live,” said Will Cooper, Jr., president and co-founder of the Cooper Housing Institute.

ImmunoScape Appoints Systems Immunology and Computational Biology Expert Dr. John Tsang to its Scientific Advisory Board

Retrieved on: 
Tuesday, December 12, 2023
Science, Other Science, Biotechnology, Research, Pharmaceutical, Oncology, General Health, Health, Biophysics, NIAID, TCR, Organization, Allen Institute, Executive Committee, National Cancer Institute, Cell Reports, University, Chan Zuckerberg Initiative, Master of Mathematics, Multimedia, Computational biology, Systems biology, Biomedicine, Allele, SAB, Machine learning, HLA, COVID-19, Kidney, Therapy, Intramural sports, NIH, World Allergy Organization, Cancer, Bangladesh Technical Education Board, CHI, Harvard University, Biomedical engineering, System, Digestive, Bachelor of Applied Science, Infection, Medical device, Management, Yale University, Columbia

ImmunoScape , a biotechnology company focused on next-generation immunotherapies, today announced the appointment of John Tsang, Ph.D. to its Scientific Advisory Board (SAB).

Key Points: 
  • ImmunoScape , a biotechnology company focused on next-generation immunotherapies, today announced the appointment of John Tsang, Ph.D. to its Scientific Advisory Board (SAB).
  • Dr. Tsang joins a distinguished group of leading scientists in immunology and oncology who help to guide ImmunoScape’s scientific strategy.
  • Dr. Tsang was also the Co-Director of the Trans-NIH Center for Human Immunology (CHI) and led its research program in systems human immunology.
  • Dr. Tsang has won multiple awards for his research, including several NIH/NIAID Merit Awards recognizing his scientific leadership in systems immunology, COVID-19, and human immunology research.

AARP Services Announces New AARP Member Benefits from Amazon, Paramount+ and Daily Harvest

Retrieved on: 
Tuesday, December 12, 2023
Sport, UEFA, Snack, Vegetable, PAW, SURVIVOR, SHOWTIME, NFL, AARP, Alexa, System, CBS, Paramount, NCIS, CBS Sports, BASS, CHI, STAR, Nightclub, Amazon

WASHINGTON, Dec. 12, 2023 /PRNewswire/ -- AARP members can take advantage of benefits and discounts this winter from three new providers.

Key Points: 
  • WASHINGTON, Dec. 12, 2023 /PRNewswire/ -- AARP members can take advantage of benefits and discounts this winter from three new providers.
  • The latest additions for the wide-ranging list of member benefits include savings and special offers from Amazon, Daily Harvest, and Paramount+.
  • "As we continue into the holiday season, we are pleased to make available more opportunities for AARP members to save," said John Larew, AARP Services President and CEO.
  • AARP commercial member benefits are provided by third parties, not by AARP or its affiliates.